Information  X 
Enter a valid email address

EPIC/TIDM matching '0UP6'

Date
Time Source
Company
Announcement
20 Oct 2020 1:30 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020
13 Oct 2020 1:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure
05 Oct 2020 2:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Participate in Upcoming Conferences
28 Sep 2020 2:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
24 Sep 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
15 Sep 2020 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually
10 Sep 2020 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Participate in Upcoming Investor Conferences
02 Sep 2020 10:14 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
31 Aug 2020 1:55 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
24 Aug 2020 2:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
17 Aug 2020 7:30 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
14 Aug 2020 6:07 am GNW Factsheet Novavax, Inc. (0UP6) Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
13 Aug 2020 1:30 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
10 Aug 2020 9:02 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reports Second Quarter 2020 Financial and Operational Results
07 Aug 2020 10:26 am GNW Factsheet Novavax, Inc. (0UP6) Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
06 Aug 2020 9:50 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax and Serum Institute of India Announce Development and Commercial Collaboration
  11:45 am GNW Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Second Quarter Financial and Operating Results on August 10, 2020
04 Aug 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
23 Jul 2020 9:02 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate
20 Jul 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present COVID-19 Vaccine Candidate Progress at 2nd ISV COVID-19 Vaccines Virtual Congress
07 Jul 2020 11:00 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces $1.6 Billion Funding from Operation Warp Speed
02 Jul 2020 1:30 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces Updates to Leadership Team
29 Jun 2020 1:42 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Expands Executive Leadership and Announces Key Promotions
24 Jun 2020 1:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Participate in H.C. Wainwright Fireside Chat Series
17 Jun 2020 1:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Announces Additions to Executive Leadership
16 Jun 2020 1:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
15 Jun 2020 3:09 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Raise $200 Million from Private Placement with RA Capital
08 Jun 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
05 Jun 2020 1:04 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Awarded Department of Defense Contract for COVID-19 Vaccine
27 May 2020 1:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Expands Large-Scale Global Manufacturing Capacity
25 May 2020 9:30 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
11 May 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reports First Quarter 2020 Financial Results
  9:02 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
  4:53 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series
06 May 2020 2:15 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020
08 Apr 2020 11:00 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
24 Mar 2020 10:00 am GNW Factsheet Novavax, Inc. (0UP6) Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
11 Mar 2020 8:17 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reports Fourth Quarter and Full Year 2019 Financial Results
  2:45 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate
10 Mar 2020 9:30 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development
05 Mar 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results on March 11, 2020
26 Feb 2020 2:27 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Advances Development of Novel COVID-19 Vaccine
25 Feb 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity
15 Jan 2020 1:30 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Granted Fast Track Designation for NanoFlu in Older Adults
09 Jan 2020 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference
07 Nov 2019 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reports Third Quarter 2019 Financial Results
31 Oct 2019 8:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019
15 Oct 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
19 Sep 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference
06 Sep 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference
12 Aug 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
08 Aug 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting
07 Aug 2019 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reports Second Quarter 2019 Financial Results
05 Aug 2019 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu
01 Aug 2019 2:25 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
31 Jul 2019 9:30 pm GNW Factsheet Novavax, Inc.; Catalent Biolog (0UP6) Novavax and Catalent Announce Closing of Strategic Partnership
27 Jun 2019 12:00 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
  11:59 am GNW Factsheet Novavax, Inc. (0UP6) Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities
10 Jun 2019 11:59 am GNW Factsheet Novavax, Inc. (0UP6) Novavax Provides Updates on the Global Pathways to Licensure for ResVax™
04 Jun 2019 9:05 pm GNW Factsheet Novavax, Inc. (0UP6) Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t